{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:19:21Z","timestamp":1774117161226,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"BMBF","doi-asserted-by":"publisher","award":["01KI07145"],"award-info":[{"award-number":["01KI07145"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"BMBF","doi-asserted-by":"publisher","award":["01KI1204"],"award-info":[{"award-number":["01KI1204"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.052","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T09:53:22Z","timestamp":1458813202000},"page":"2342-2348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay"],"prefix":"10.1016","volume":"34","author":[{"given":"Mathias W.","family":"Pletz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Ewig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartwig","family":"Schuette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Forstner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.052_bib0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0032-1310103","article-title":"The burden of pneumococcal pneumonia \u2013 experience of the German competence network CAPNETZ","volume":"66","author":"Pletz","year":"2012","journal-title":"Pneumologie"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.12703\/P6-82","article-title":"Recent advances in our understanding of Streptococcus pneumoniae infection","volume":"6","author":"Feldman","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0160","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0165","series-title":"Community-acquired pneumonia","first-page":"266","article-title":"Pneumococcal and influenza vaccination","author":"Pletz","year":"2014"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0170","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0175","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/INF.0b013e3182624a40","article-title":"Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta","volume":"31","author":"Leal","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0185","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JCM.43.10.4972-4976.2005","article-title":"Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection","volume":"43","author":"Leeming","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0190","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CVI.00064-12","article-title":"Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine","volume":"19","author":"Pride","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0195","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s15010-004-3107-z","article-title":"CAPNETZ-community-acquired pneumonia competence network","volume":"32","author":"Welte","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0200","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0205","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1183\/09031936.00041210","article-title":"The paradox in pneumococcal sero-types: highly invasive does not mean highly lethal","volume":"36","author":"Pletz","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2466-14-128","article-title":"Pneumococcal pneumonia: differences according to blood culture results","volume":"14","author":"Capelastegui","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0215","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.07-1322","article-title":"The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study","volume":"133","author":"Bordon","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0220","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1017\/S0950268810002402","article-title":"Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae","volume":"139","author":"Lin","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0225","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1525-1497.2000.04429.x","article-title":"Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia","volume":"15","author":"Brandenburg","year":"2000","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2007.03.015","article-title":"A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia","volume":"19","author":"Jover","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0235","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1513\/AnnalsATS.201505-304OC","article-title":"Sensitivity, specificity and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia","volume":"12","author":"Molinos","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9343(99)00050-9","article-title":"Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia","volume":"106","author":"Ruiz-Gonzalez","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0245","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/infdis\/jit506","article-title":"Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged \u226550 years with community-acquried pneumonia","volume":"208","author":"Sherwin","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0250","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1183\/13993003.00325-2015","article-title":"Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands","volume":"46","author":"Mangen","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0255","first-page":"131","article-title":"[Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2013]","volume":"16","author":"Robert Koch Institute","year":"2015","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0260","first-page":"743","article-title":"Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850000 individuals","volume":"110","author":"Theidel","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0265","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2213-2600(14)70032-3","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis","volume":"2","author":"Simonsen","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0275","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0280","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0285","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on pneumococcal invasive disease and carriage in Stockholm Sweden","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.03.052_bib0290","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/21645515.2015.1102811","article-title":"Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: should we expect herd protection of adults through infants\u2019 vaccination?","volume":"12","author":"Azzari","year":"2016","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T03:46:05Z","timestamp":1691898365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16300354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16300354"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}